本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

天美生物

1.48
+0.07004.96%
成交量:55.18万
成交额:82.08万
市值:556.10万
市盈率:0.36
高:1.53
开:1.46
低:1.44
收:1.41
52周最高:73.75
52周最低:1.14
股本:375.74万
流通股本:365.83万
量比:9.31
换手率:15.08%
股息:- -
股息率:- -
每股收益(TTM):4.17
每股收益(LYR):4.17
净资产收益率:0.91%
总资产收益率:2.16%
市净率:0.13
市盈率(LYR):0.36

数据加载中...

2025/04/16

SEC问询函

Form CORRESP - Correspondence
2025/04/16

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2025/04/02

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/14

SEC问询函

Form CORRESP - Correspondence
2025/03/14

SEC问询函

Form CORRESP - Correspondence
2025/03/13

SEC问询函

Form CORRESP - Correspondence
2025/03/13

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/03/06

SEC问询函

Form CORRESP - Correspondence
2025/03/03

SEC问询函

Form CORRESP - Correspondence
2025/03/03

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/02/19

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/02/18

SEC问询函

Form CORRESP - Correspondence
2025/01/28

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/01/17

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/01/16

SEC问询函

Form CORRESP - Correspondence
2024/11/19

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/10/11

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/10/11

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/02/09

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/05/15

SEC问询函

Form CORRESP - Correspondence